Rafferty Asset Management, LLC Abb Vie Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 266,344 shares of ABBV stock, worth $47.9 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

266,344

Previous 301,991 11.8%

Holding current value

$47.9 Million

Previous $51.8 Million 1.54%

% of portfolio

0.18%

Previous 0.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $5.84 Million - $7.11 Million	-35,647 Reduced 11.8%	266,344 $52.6 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $10.6 Million - $12.4 Million	68,502 Added 29.34%	301,991 $51.8 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $1.02 Million - $1.16 Million	-6,385 Reduced 2.66%	233,489 $42.5 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $557,142 - $627,473	-4,049 Reduced 1.66%	239,874 $37.2 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $1.76 Million - $2.04 Million	13,173 Added 5.71%	243,923 $36.4 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $3.59 Million - $4.47 Million	27,121 Added 13.32%	230,750 $31.1 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $291,099 - $335,245	2,013 Added 1.0%	203,629 $32.5 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $8.01 Million - $9.61 Million	57,947 Added 40.33%	201,616 $32.6 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $9.94 Million - $11.4 Million	74,096 Added 106.5%	143,669 $19.3 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $2.8 Million - $3.56 Million	-20,343 Reduced 22.62%	69,573 $10.7 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $1.52 Million - $1.89 Million	-11,537 Reduced 11.37%	89,916 $14.6 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $1.71 Million - $2.16 Million	15,900 Added 18.58%	101,453 $13.7 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $2.81 Million - $3.19 Million	26,394 Added 44.62%	85,553 $9.23 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $592,647 - $660,243	-5,633 Reduced 8.69%	59,159 $6.66 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $2.69 Million - $2.96 Million	26,249 Added 68.1%	64,792 $7.01 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $1.28 Million - $1.73 Million	-15,949 Reduced 29.27%	38,543 $4.13 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $100,772 - $118,273	1,173 Added 2.2%	54,492 $4.77 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $2.51 Million - $3.36 Million	34,255 Added 179.68%	53,319 $5.24 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $4.23 Million - $6.41 Million	-65,533 Reduced 77.46%	19,064 $1.45 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $721,588 - $902,861	-10,004 Reduced 10.57%	84,597 $7.49 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $1.45 Million - $1.75 Million	23,052 Added 32.22%	94,601 $7.16 Million
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $316,345 - $404,363	4,815 Added 7.22%	71,549 $5.2 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $5.15 Million - $6.06 Million	66,734 New	66,734 $5.38 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $2.96 Million - $3.5 Million	-32,978 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $3.03 Million - $4.06 Million	32,978 New	32,978 $3.12 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $4.15 Million - $4.55 Million	-46,336 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $3.24 Million - $4.13 Million	46,336	46,336 $4.12 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Abb Vie Inc. Transaction History